Dapsone acetylation in man: another example of polymorphic acetylation.
作者信息
Peters J H, Levy L
出版信息
Ann N Y Acad Sci. 1971 Jul 6;179:660-6. doi: 10.1111/j.1749-6632.1971.tb46942.x.
Abstract
摘要
相似文献
1
Dapsone acetylation in man: another example of polymorphic acetylation.人类中的氨苯砜乙酰化：多态性乙酰化的另一个例子。
Ann N Y Acad Sci. 1971 Jul 6;179:660-6. doi: 10.1111/j.1749-6632.1971.tb46942.x.
2
The polymorphic acetylation of dapsone in man.氨苯砜在人体内的多态性乙酰化作用。
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):225-38. doi: 10.1002/cpt1971122part1225.
3
Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.氨苯砜在耐氨苯砜麻风病患者中的代谢情况。
Am J Trop Med Hyg. 1974 Mar;23(2):222-30. doi: 10.4269/ajtmh.1974.23.222.
4
Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.南印度受试者中抗菌药物磺胺二甲嘧啶和氨苯砜的多态性乙酰化
Am J Trop Med Hyg. 1975 Jul;24(4):641-8. doi: 10.4269/ajtmh.1975.24.641.
5
The diposition of the antileprotic drug dapsone (DDS) in Philippine subjects.抗麻风病药物氨苯砜（DDS）在菲律宾受试者体内的处置情况。
Am J Trop Med Hyg. 1972 Jul;21(4):450-7. doi: 10.4269/ajtmh.1972.21.450.
6
The effect of rifampicin on dapsone metabolism.利福平对氨苯砜代谢的影响。
Proc West Pharmacol Soc. 1975;18:330-4.
7
Dapsone metabolism in patients with dapsone-resistant leprosy.耐氨苯砜麻风病患者体内氨苯砜的代谢
Am J Trop Med Hyg. 1975 Nov;24(6 Pt 1):963-7. doi: 10.4269/ajtmh.1975.24.963.
8
Polymorphic acetylation of drugs in rabbits.家兔体内药物的多态性乙酰化
Xenobiotica. 1973 Mar;3(3):133-50. doi: 10.3109/00498257309151508.
9
Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
Lepr India. 1977 Jan;49(1):59-64.
10
Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.同时给予N-乙酰转移酶的其他底物对氨苯砜乙酰化的影响。
Br J Clin Pharmacol. 1981 Jul;12(1):83-6. doi: 10.1111/j.1365-2125.1981.tb01860.x.
引用本文的文献
1
[Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report].[氨苯砜所致粒细胞缺乏症。通过一例病例报告阐述的异生物质代谢酶的作用]
Hautarzt. 2005 Jul;56(7):673-7. doi: 10.1007/s00105-004-0877-2.
2
Drug-related lupus. Incidence, mechanisms and clinical implications.药物性狼疮。发病率、机制及临床意义。
Drug Saf. 1991 Nov-Dec;6(6):431-49. doi: 10.2165/00002018-199106060-00004.
3
Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.对人类研究中终末半衰期、原形药物排泄百分比以及肾功能和肝功能不全时半衰期变化进行批判性汇编，并列出参考文献。
J Pharmacokinet Biopharm. 1975 Oct;3(5):333-83. doi: 10.1007/BF01082306.
4
Disease and acetylation polymorphism.疾病与乙酰化多态性
Clin Pharmacokinet. 1977 May-Jun;2(3):182-97. doi: 10.2165/00003088-197702030-00003.
Zotero 插件